BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Nov. 8, 2006
View Archived Issues
Intercell Gets $9.5M Up Front In Potential $85M Merck Deal
Intercell AG earned an up-front payment of $9.5 million and could receive up to $76 million more in milestones from an agreement with Merck Sharpe & Dhome Research Ltd., an arm of Merck & Co. Inc. (BioWorld International)
Read More
Archimedes Builds Portfolio Through Acquisition Of Link
Read More
Target Discovered That Could Help In Muscle Regeneration
Read More
European Union Tightens Rules On Human Cells And Tissues
Read More
Innate Pharma Completes €30M Initial Public Offering In Paris
No Abstract
Read More
IntegraGen, Royal DSM Partner In Area Of Weight Management
Read More
UK Streamlines Process For Conducting Trials In Patients
Read More
Other News To Note
Read More